Association of SARS-CoV-2 Seropositivity With Myalgic Encephalomyelitis and/or Chronic Fatigue Syndrome Among Children and Adolescents in Germany. — CFSMEATLAS
Association of SARS-CoV-2 Seropositivity With Myalgic Encephalomyelitis and/or Chronic Fatigue Syndrome Among Children and Adolescents in Germany.
Sorg, Anna-Lisa, Becht, Selina, Jank, Marietta et al. · JAMA network open · 2022 · DOI
Quick Summary
This study looked at whether children and teenagers who had been infected with the virus that causes COVID-19 were more likely to develop ME/CFS symptoms like severe fatigue and muscle pain. Researchers tested 634 young people in Germany and found that those who had been infected with COVID-19 showed only slightly higher rates of ME/CFS symptoms compared to those who hadn't been infected. The increase was small enough that other factors—like stress from lockdowns—might explain the symptoms just as well.
Why It Matters
Understanding whether COVID-19 infection specifically causes ME/CFS in children is critical for differentiating post-viral ME/CFS from pandemic-related psychological or social effects. This study provides empirical data on a large pediatric cohort during early pandemic phases, helping clarify the true association between SARS-CoV-2 and ME/CFS development in youth—information essential for clinical assessment and public health guidance.
Observed Findings
40% of seropositive children (40/100) reported clustered ME/CFS symptoms versus 29.6% of seronegative children (158/534)
Unadjusted risk ratio for clustered ME/CFS symptoms in seropositive children was 1.35 (95% CI 1.03-1.78), which decreased to 1.18 after adjustment for sex, age group, and preexisting disease
Unadjusted risk ratio for substantial fatigue was 2.45 (95% CI 1.24-4.84), which decreased to 2.08 after adjustment
When analysis was limited to children with known infection status (n=610), adjusted risk ratio dropped to 1.08 (95% CI 0.80-1.46) for clustered ME/CFS symptoms
Inferred Conclusions
The risk of ME/CFS in children and adolescents from SARS-CoV-2 infection alone may be very small, with much of the apparent association attributable to confounding variables
Recall bias in parental questionnaires may substantially inflate estimates of long COVID symptom prevalence in pediatric populations
Pandemic-related factors such as lockdowns and confinement warrant consideration as explanations for complex, nonspecific symptoms in children during COVID-19 rather than direct viral causation
Remaining Questions
Does the association between SARS-CoV-2 seropositivity and ME/CFS symptoms differ in children who experienced documented symptomatic COVID-19 versus those with asymptomatic infection?
How do recall bias and time lag between infection and symptom assessment affect the true association, and can prospective cohort designs reduce this bias?
What This Study Does Not Prove
This study does not prove that COVID-19 cannot cause ME/CFS in children; the observed associations, while modest, remain statistically present in unadjusted analyses. The cross-sectional design cannot establish causation or temporal sequence. Recall bias in parental reporting and the possibility that unmeasured confounders (such as pandemic stress) explain the associations cannot be excluded. Results from mid-2021 Germany may not generalize to other populations or variants.
What is the relative contribution of pandemic-related psychosocial stressors (lockdowns, school closures, social isolation) versus direct viral mechanisms in explaining ME/CFS-like symptoms in youth?
Do findings from mid-2021 Germany generalize to other time periods, geographic regions, and SARS-CoV-2 variants?